VERTEX PHARMACEUTICALS INC

Ticker: VRTX CUSIP: 92532F100 Class: EQTY

Smith Group Asset Management, LLC's Holding History (CIK: 0001893134)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 52,051 Value ($000) $23,598 Avg Close $431.03 Range $392.50 - $464.44
Q3 2025
Shares 48,857 Value ($000) $19,134 Avg Close $417.92 Range $362.50 - $484.56
Q2 2025
Shares 46,255 Value ($000) $20,593 Avg Close $460.83 Range $416.60 - $510.77
Q1 2025
Shares 45,643 Value ($000) $22,129 Avg Close $466.00 Range $397.25 - $519.68
Q4 2024
Shares 43,633 Value ($000) $17,571 Avg Close $463.53 Range $377.85 - $519.88
Q3 2024
Shares 43,659 Value ($000) $20,305 Avg Close $480.37 Range $456.07 - $510.64
Q2 2024
Shares 42,910 Value ($000) $20,113 Avg Close $434.05 Range $391.01 - $486.43
Q1 2024
Shares 41,038 Value ($000) $17,154 Avg Close $422.74 Range $403.43 - $448.40
Q4 2023
Shares 36,584 Value ($000) $14,886 Avg Close $369.42 Range $341.85 - $413.00
Q1 2022
Shares 19,060 Value ($000) $4,974 Avg Close $237.33 Range $214.66 - $263.58